FDA Clears Bracco and Avicenna.AI's CT Tool for Incidental Brain Aneurysms
The software flags previously undetected vascular findings in routine scans, a use case where AI augments radiologists rather than replacing reads.
Independent reporting on the systems, capital and science shaping the technology industry.
Computational drug discovery, robotic surgical suites, FDA-approved clinical AI models, and brain-computer interfaces.
The software flags previously undetected vascular findings in routine scans, a use case where AI augments radiologists rather than replacing reads.
The system analyzes EEG data to flag indicators in children aged three to five, offering an earlier and more objective screening path.
The company passed the agency's Predetermined Change Control Plan process, allowing it to update its model without a new submission each time.
Public comments on the agency's draft generative AI framework reveal a health system still working out who is responsible when a model is wrong.